We are proud to announce that Dr. Keyue Sun and the Schlegel Lab have been selected as the inaugural recipients of the NADMED Award for their work on metabolic assessment of organ viability in transplantation. Their research tackles a critical question in transplant medicine: How can we determine whether a donor organ is truly viable? Using NAD⁺/NADH redox profiling, the team is investigating mitochondrial function during ischemia and machine perfusion – key phases where organ fate is often decided.
Why does this matter?
– Mitochondrial dysfunction is a key driver of transplant outcomes.
– Current tools to assess metabolic state remain limited.
– Better measurement could significantly improve clinical decision-making.
This is exactly the kind of work the NADMED Award was created to support: research that translates redox biology into real clinical impact.